Risk factors for squamous intraepithelial lesions (SIL) of the cervix among women residing at the US-Mexico border

International Journal of Cancer

Volumn 109, Issue 1, 2004, Pages 112-118

  Giuliano, Anna R ^a,b   Papenfuss, Mary ^a   Mendez Brown De Galaz, Elena ^c   Feng, Janine ^d   Abrahamsen, Martha ^a   Denman, Catalina ^e   Guernsey De Zapien, Jill ^a,b   Navarro Henze, Jose Luis ^f   Garcia, Francisco ^d   Hatch, Kenneth ^d  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c CENTRO MÉDICO NACIONAL 20 DE NOVIEMBRE   (Mexico)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^e El Colegio de Sonora   (Mexico)

^f Servicios de Salud de Sonora   (Mexico)

Author keywords

Cervical cancer; Cervical dysplasia; HPV; Squamous intraepithelial lesions; Viral load

Indexed keywords

GENOMIC DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHLAMYDIA TRACHOMATIS; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; METABOLISM; MEXICO; MICROBIOLOGY; NUCLEOTIDE SEQUENCE; PAPANICOLAOU TEST; PATHOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK; RISK FACTOR; SEXUAL BEHAVIOR; TIME; UNITED STATES; UTERINE CERVIX; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR; VIRUS DETECTION; VIRUS LOAD; WART VIRUS;

ADOLESCENT; ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CHLAMYDIA TRACHOMATIS; FEMALE; HUMANS; MEXICO; MIDDLE AGED; ODDS RATIO; RISK FACTORS; TIME FACTORS; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 10744233162     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11656     Document Type: Article

References (31)

1. Bosch F, de Sanjose S. Limitations of the evidence and areas of further research. J Natl Cancer Inst Monogr 2003;31:3-13.
2. Castellsague X, Munoz N. Co-factors in HPV carcinogenesis: the role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 2003;31:20-8.
3. Castle PE, Giuliano AR. HPV co-factors, cervical microenvironment, and cervical cancer. J Natl Cancer Inst Monogr 2003;31:29-34.
4. Giuliano AR, Denman C, Guernsey de Zapien J, Navarro Henze JL, Ortega L, Djambazov B, Mendez Brown de Galaz E, Hatch K. Design and results of the USA-Mexico border human papillomavirus (HPV), cervical dysplasia, and Chlamydia trachomatis study. Rev Panam Salud Publica 2001;9:172-81.
5. The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. National Cancer Institute Workshop. JAMA 1989;262:931-4.
6. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000;38:357-61.
7. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998;36:3020-7.
8. Morrison EA, Ho GY, Vermund SH, Goldberg GL, Kadish AS, Kelley KF, Burk RD. Human papillomavirus infection and other risk factors for cervical neoplasia: a case-control study. Int J Cancer 1991;49:6-13.
9. Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, Basu J, Tachezy R, Lewis R, Romney S. Persistent genital human papilloma-virus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:1365-71.
10. Ho GY, Kadish AS, Burk RD, Basu J, Palan PR, Mikhail M, Romney SL. HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia. Int J Cancer 1998;78:281-5.
11. Ho GY, Palan PR, Basu J, Romney SL, Kadish AS, Mikhail M, Wassertheil-Smoller S, Runowicz C, Burk RD. Viral characteristics of human papillomavirus infection and antioxidant levels as risk factors for cervical dysplasia. Int J Cancer 1998;78:594-9.
12. Moreno V, Munoz N, Bosch FX, de Sanjose S, Gonzalez LC, Tafur L, Gili M, Izarzugaza I, Navarro C, Vergara A, Viladiu P, Ascunce N, et al. Risk factors for progression of cervical intraepithelial neoplasm grade III to invasive cervical cancer. Cancer Epidemiol Biomarkers Prev 1995;4:459-67.
13. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995;172:946-54.
14. Hall S, Lorincz A, Shah F, Sherman ME, Abbas F, Paull G, Kurman RJ, Shah KV. Human papillomavirus DNA detection in cervical specimens by hybrid capture: correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix. Gynecol Oncol 1996;62:353-9.
15. Holly EA, Ralston ML, Darragh TM, Greenblatt RM, Jay N, Palefsky JM. Prevalence and risk factors for anal squamous intraepithelial lesions in women. J Natl Cancer Inst 2001;93:843-9.
16. Sherman ME, Schiffman M, Cox JT. Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). J Natl Cancer Inst 2002;94:102-7.
17. Healey SM, Aronson KJ, Mao Y, Schlecht NF, Mery LS, Ferenczy A, Franco EL. Oncogenic human papillomavirus infection and cervical lesions in aboriginal women of Nunavut, Canada. Sex Trans Dis 2001;28:694-700.
18. Sun CA, Lai HC, Chang CC, Neih S, Yu CP, Chu TY. The significance of human papillomavirus viral load in prediction of histologic severity and size of squamous intraepithelial lesions of uterine cervix. Gynecol Oncol 2001;83:95-9.
19. Sun CA, Liu JF, Wu DM, Nieh S, Yu CP, Chu TY. Viral load of high-risk human papillomavirus in cervical squamous intraepithelial lesions. Int J Gynaecol Obstet 2002;76:41-7.
20. Clavel C, Masure M, Bory JP, Putaud I, Mangeonjean C, Lorenzato M, Nazeyrollas P, Gabriel R, Quereux C, Birembaut P. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer 2001;84:1616-23.
21. Schneider A, Zahm DM, Kirchmayr R, Schneider VL. Screening for cervical intraepithelial neoplasia grade 2/3: validity of cytologic study, cervicography, and human papillomavirus detection. Am J Obstet Gynecol 1996;174:1534-41.
22. Nindl I, Lorincz A, Mielzynska I, Petry U, Baur S, Kirchmayr R, Michels W, Schneider A. Human papillomavirus detection in cervical intraepithelial neoplasia by the second-generation hybrid capture microplate test, comparing two different cervical specimen collection methods. Clin Diagn Virol 1998;10:49-56.
23. Lorincz AT, Castle PE, Sherman ME, Scott DR, Glass AG, Wacholder S, Rush BB, Gravitt PE, Schussler JE, Schiffman M. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 2002;360:228-9.
24. Swan DC, Tucker RA, Tortolero-Luna G, Mitchell MF, Wideroff L, Unger ER, Nisenbaum RA, Reeves WC, Icenogle JP. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J Clin Microbiol 1999;37:1030-4.
25. van Duin M, Snijders PJ, Schrijnemakers HF, Voorhorst FJ, Rozendaal L, Nobbenhuis MA, van den Brute AJ, Verheijen RH, Helmerhorst TJ, Meijer CJ. Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int J Cancer 2002;98:590-5.
26. Peitsaro P, Johansson B, Syrjanen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 2002;40:886-91.
27. Ylitalo N, Sorensen P, Josefsson AM, Magnusson PK, Andersen PK, Ponten J, Adami HO, Gyllensten UB, Melbye M. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 2000;355:2194-8.
28. Beskow AH, Gyllensten UB. Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri. Int J Cancer 2002;101:526-31.
29. Wang SS, Hildesheim A. Viral and host factors in HPV persistence and progression. J Natl Cancer Inst Monogr 2003;31:35-40.
30. Giuliano AR, Papenfuss M, Abrahamsen M, Inserra P. Differences in factors associated with oncogenic and nononcogenic human papillomavirus infection at the United States-Mexico border. Cancer Epidemiol Biomarkers Prev 2002;11:930-4.
31. Castle PE, Hillier SL, Rabe LK, Hildesheim A, Herrero R, Bratti MC, Sherman ME, Burk RD, Rodriguez AC, Alfaro M, Hutchinson ML, Morales J, et al. An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev 2001;10:1021-7.